Rational Engineering of Recombinant Picornavirus Capsids to Produce Safe, Protective Vaccine Antigen
Claudine Porta(The Pirbright Institute), Bryan Charleston(The Pirbright Institute), Alison Burman(The Pirbright Institute), Jingshan Ren(Centre for Human Genetics), Silvia Loureiro(University of Reading), Elizabeth E. Fry(University of Oxford), Ian M. Jones(University of Leeds), Abhay Kotecha(Thermo Fisher Scientific (Netherlands)), Terry Jackson(Unknown), David I. Stuart(MRC Laboratory of Molecular Biology)
Cited by 154
Related Papers
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
|Nature Immunology|2020|1.4k
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
|Cell|2021|1.2k
Structure-based classification of tauopathies
|Nature|2021|916
Antibody evasion by the P.1 strain of SARS-CoV-2
|Cell|2021|661